Controlled Substances Studies & Analysis

PolyCrystalLine received the authorization N°487/2016 from the Italian Ministry of Healthfor the study and chemical/physical analysis of controlled substances. Polycrystalline has invested in ca

Read all

9th Crystal Forms@BO Convention

9th CRYSTAL FORMS@BO CONVENTION (4-6th June 2017, Bologna)  “CRYSTALLIZATION BY DESIGN” Making, discovering, protecting and using crystal forms ABOUT THE CONVENTION The invest

Read all

Highly Potent API

Polycrystalline is expanding its HPAPI offerings, up to OEB 5 level of containment for the synthesis, study and development of anti-cancer and cytotoxic APIs. Polycrystalline has invested in capacity

Read all

Minodronic Acid novel form

PolyCrystalLine discovered a novel crystalline form of Minodronic Acid and filed a patent application. For additional information contact

Read all

“... every compound has
different polymorphic forms...
and the number of forms known for a given
compound is proportional to the time and
money spent in research on that compound.”

McCrone, 1965‏

© Copyright Polycrystalline SpA - All rights reserved - VAT IT02600021204 / powered by DibiWeb